Wheat starch-Lonicera caerulea berry polyphenols complex regulates blood glucose and improves intestinal flora in type 2 diabetic mice.

Carbohydr Polym

Engineering Research Center of Chestnut Industry Technology of Ministry of Education, College of Food Science & Technology, Hebei Normal University of Science and Technology, Qinhuangdao, Hebei 066004, China.

Published: March 2025

Resistant starch (RS) reduces or delays the digestion of carbohydrates and glucose synthesis, thereby lowering postprandial blood glucose levels. The wheat starch-Lonicera caerulea berry polyphenols (WS-LCBP) complex was constructed using high hydrostatic pressure (HHP). The effects of intragastric administration of WS or WS-LCBP on blood glucose in T2DM model mice. RS in the composite preparation formed by HHP and 10 % LCBP at 600 MPa for 30 min increased from 7.65 % to 49.66 %. WS-LCBP formed an A + V-type crystal structure of the polyhydroxyl non-inclusion complex, which hindered the digestion of WS into glucose. Compared with LCBP intake, which caused 8.3 % reduction in 2-h postprandial blood glucose (p < 0.05), Homeostatic model assessment for insulin resistance demonstrated a 35.3 % decrease (p < 0.001) with WS-LCBP administration. Western blotting demonstrated that exposure to WS-LCBP activated the GLP-1R/PI3K/AKT signaling pathway in the liver tissue of T2DM mice, reducing insulin resistance. Furthermore, the concentration of short-chain fatty acids was markedly elevated. The structure and abundance of the intestinal flora were enhanced. The WS-LCBP complex demonstrated a more pronounced improvement than LCBP supplementation alone. This study offers a novel perspective and theoretical foundation for the regulation of postprandial blood glucose levels by polyphenol starch-based food biomacromolecules and their potential applications in starchy foods.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carbpol.2024.123061DOI Listing

Publication Analysis

Top Keywords

blood glucose
16
wheat starch-lonicera
8
starch-lonicera caerulea
8
caerulea berry
8
berry polyphenols
8
postprandial blood
8
glucose
6
polyphenols complex
4
complex regulates
4
blood
4

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

AIMST University, Bedong, Kedah, Malaysia.

Background: Senile dementia (SD) is a deteriorative organic brain disorder and it comprises Alzheimer's disease (AD) as a major variant. SD is shown impairment of mental capacities whereas AD is degeneration of neurons. According to World Health Organization (WHO) report; more than 55 million peoples have dementia and it is raising 10 million new cases every year.

View Article and Find Full Text PDF

Background: Abnormal glucose metabolism in AD brains correlates with cognitive deficits. The glucose changes are consistent with brain thiamine (vitamin B1) deficiency. In animals, thiamine deficiency causes multiple AD-like changes including memory loss, neuron loss, brain inflammation, enhanced phosphorylation of tau, exaggerated plaque formation and elevated advanced glycation end products (AGE).

View Article and Find Full Text PDF

Background: Diabetic conditions are associated with alterations in brain functions like memory deficits through processes like synaptic dysfunction in the hippocampus. Administering a combination of silver nanonaringenin and vitamin E appears promising since they are known to prevent diabetes and memory deficits in previous studies, and nanoformulation of naringenin may be one way to improve delivery and bioavailability of naringenin in the brain. This study investigated the effects of co-administering silver nanonaringenin and vitamin E against memory deficits and synaptic dysfunction in the hippocampus of a mice model of high-fat diet and streptozotocin (HS).

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Burke Neurological Institute, Weill Cornell Medicine, White Plains, NY, USA.

Background: Benfotiamine, a prodrug of thiamine, raises blood levels by 50-100 times to achieve pharmacologic effects. It provides a novel therapeutic direction addressing a well-characterized brain tissue thiamine deficiency and related changes in glucose metabolism in AD. BenfoTeam is a seamless phase 2A-2B "proof of concept" (POC), double-blind, placebo-controlled RCT investigating tolerability, safety, and efficacy of benfotiamine, as a first-in-class small molecule treatment for early AD.

View Article and Find Full Text PDF

Background: Aerobic exercise may positively affect brain health, although relationships with cognitive change are mixed. This likely is due to individual differences in the systemic physiological response to exercise. However, the acute effects of exercise on brain metabolism and biomarker responses are not well characterized in older adults or cognitively impaired individuals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!